Aspen Aerogels, Inc. (NYSE:ASPN) Receives Consensus Recommendation of “Buy” from Analysts

Shares of Aspen Aerogels, Inc. (NYSE:ASPN) have received an average rating of “Buy” from the nine ratings firms that are presently covering the company, Marketbeat Ratings reports. Eight equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $30.00.

A number of analysts have issued reports on ASPN shares. StockNews.com raised Aspen Aerogels to a “sell” rating in a research note on Wednesday, November 13th. Roth Mkm reduced their target price on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a research note on Friday, November 8th. HC Wainwright reiterated a “buy” rating and issued a $30.00 target price on shares of Aspen Aerogels in a report on Wednesday, October 16th. Piper Sandler cut their price target on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a report on Tuesday, October 22nd. Finally, Barclays decreased their price objective on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a report on Tuesday, November 12th.

Aspen Aerogels Price Performance

NYSE:ASPN opened at $11.88 on Thursday. Aspen Aerogels has a one year low of $10.75 and a one year high of $33.15. The stock has a market cap of $974.72 million, a PE ratio of 1,189.19 and a beta of 2.12. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93. The stock has a 50 day moving average price of $14.72 and a 200 day moving average price of $21.31.

Institutional Investors Weigh In On Aspen Aerogels

Several institutional investors and hedge funds have recently modified their holdings of ASPN. Lord Abbett & CO. LLC purchased a new position in Aspen Aerogels during the 3rd quarter valued at about $10,126,000. Franklin Resources Inc. boosted its stake in shares of Aspen Aerogels by 5.3% in the third quarter. Franklin Resources Inc. now owns 29,418 shares of the construction company’s stock valued at $815,000 after purchasing an additional 1,483 shares during the period. Wilmington Savings Fund Society FSB acquired a new position in shares of Aspen Aerogels in the third quarter valued at approximately $498,000. Geode Capital Management LLC grew its holdings in shares of Aspen Aerogels by 5.7% in the third quarter. Geode Capital Management LLC now owns 1,385,968 shares of the construction company’s stock valued at $38,385,000 after purchasing an additional 75,024 shares in the last quarter. Finally, Barclays PLC increased its stake in Aspen Aerogels by 333.8% during the 3rd quarter. Barclays PLC now owns 92,302 shares of the construction company’s stock worth $2,557,000 after buying an additional 71,024 shares during the period. Hedge funds and other institutional investors own 97.64% of the company’s stock.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.